Vvax001 Cancer Vaccine in Premalignant Cervical Lesions – Phase II
Condition(s):CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 InfectionLast Updated:August 29, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 InfectionLast Updated:August 29, 2023Recruiting
Condition(s):Cervical DysplasiaLast Updated:November 12, 2020Withdrawn
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:November 19, 2013Completed
Condition(s):Human Papilloma VirusLast Updated:June 16, 2021Unknown status
Condition(s):Human Papillomavirus InfectionLast Updated:January 10, 2024Completed
Condition(s):HPV Infection; CIN1Last Updated:January 19, 2024Completed
Condition(s):Cervical Intraepithelial Neoplasia 3Last Updated:July 2, 2017Unknown status
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:August 7, 2013Completed
Condition(s):Infections, PapillomavirusLast Updated:June 10, 2019Completed
Condition(s):Infections, Papillomavirus; Papillomavirus VaccinesLast Updated:January 2, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.